Gilead, BioMarin among Bay Area drug makers shamed by FDA in generics ‘gaming’ list

Calling it an effort to bring transparency to the development of low-cost generic drugs, the Food and Drug Administration on Thursday released a list of drug developers who have received requests from generic drug makers for access to the branded drugs.

The agency said it has not independently investigated or confirmed that brand-name drug makers listed in a post to the agency’s website limited access to samples of the branded drugs. But the list is an unusual public shaming by the agency of several…